Abstract
The aim of the TRYTON trial was to demonstrate the safety and efficacy of the TRYTON Side Branch (SB) Stent™ compared to a provisional stenting strategy in treating native coronary true bifurcation lesions. Nine-month angiographic follow-up (FU) was performed in a pre-specified cohort of
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
